Can Intel be reborn after a blood transfusion?
In the development process of the technology industry, Intel was undoubtedly the king, occupying a dominant position in the chip market for a long time.
moreIn the development process of the technology industry, Intel was undoubtedly the king, occupying a dominant position in the chip market for a long time.
moreRecently, according to the latest data from Market Research Future, the global plant-based food market is expected to exceed 30 billion US dollars in size by 2035, with a compound annual growth rate as high as 11.19% during this period.
moreRecently, Nippon Steel planned to shut down its Granite City factory in Illinois after acquiring US Steel for $14.1 billion, but was intervened by the US government with "golden stock" authority, highlighting the political risks in foreign acquisitions.
moreIn September 2025, the White House officially disclosed the framework of the TikTok US business agreement, with core terms directly targeting "six out of seven board seats to be held by Americans" and "algorithm control rights belonging to the United States", and announced that Oracle Corporation would take over the data and algorithm configuration as the "security provider".
moreIn the current global economic landscape, the trajectory of the U.S. economy has always been a focal point of attention worldwide.
moreTariff fluctuations may seem like policy tools in the short term, but in the long run, they have become a "price dilemma" for small businesses in the United States.
moreRecently, major British media have focused on the strong growth trend of Temu, a cross-border e-commerce platform under Pinduoduo.
moreRecently, the discussion surrounding Mayor Daniel Lurie’s “Family Zoning Plan” for San Francisco has sparked intense debate.
moreOn September 17th, the latest trade data released by Japan's Ministry of Finance showed that Japan's exports in August decreased by 0.1% year-on-year, marking the fourth consecutive month of decline.
moreUnder the shadow of the Trump administration's tariff threats, global pharmaceutical giants are embarking on an unprecedented "wave of investment in the US."
more